Eden's pricing has shifted multiple times in 2026, and it's currently close to what Luma Health charges.
Different snapshots across 2026 show compounded semaglutide anywhere from $99 to $249/month and tirzepatide from $199 to $329/month, with conflicting information about whether a separate membership fee applies.
As of the most recent published figures, Eden's combined totals land within a few dollars of Luma Health's flat $197/$297 per month. Price probably shouldn't be your deciding factor here.
Eden (tryeden.com) is a Denver-based telehealth weight loss platform offering both compounded and brand-name GLP-1 medications. Its core pitch is a "same price at every dose" guarantee — a genuine feature, since dose-tier pricing is one of the more common sources of bill shock in this category.
What Is Eden?
Founded to compete in the fast-growing direct-to-consumer weight-loss telehealth space, Eden positions itself around simplicity and transparency in pricing, which is a genuinely different pitch than providers built around bundled coaching or insurance navigation. Whether that positioning holds up depends heavily on which of the pricing snapshots you encounter, which is exactly the problem this article works through below.
Eden also stands out for offering brand-name Wegovy, Ozempic, Zepbound, and Mounjaro alongside its compounded options, letting patients start compounded and switch to brand later without changing providers. This dual-pathway model is similar to Ro's approach, though Eden is cash-pay only for both tracks — it does not bill insurance directly for either.
Eden also offers a separate oral "Foundations Kit," combining non-GLP-1 medications like metformin, bupropion, and low-dose naltrexone, marketed as a lower-cost entry point for patients who aren't ready for or don't qualify for GLP-1 injections. This isn't a GLP-1 product and shouldn't be compared directly against Luma Health's semaglutide or tirzepatide pricing, but it's worth knowing about if you're exploring Eden's full catalog rather than a single medication.
Eden's Pricing: Why the Numbers Are Hard to Pin Down
This isn't a knock on Eden specifically — pricing volatility is common across the compounded GLP-1 telehealth market as companies adjust to shifting FDA compounding guidance, supply conditions, and competitive pressure. It just means the diligence burden on the patient is higher than it should be.
Researching Eden's actual current price is more difficult than it should be. Multiple independent reviews published across 2026 show meaningfully different figures for the same product, suggesting Eden has revised its pricing more than once this year.
Eden's published pricing, across different 2026 snapshots
We're presenting all three because we can't responsibly collapse them into one number and call it settled — check Eden's live pricing page directly at tryeden.com. Taking the most recent figures at face value, Eden's combined semaglutide total (~$198/month) and tirzepatide total (~$298/month) both land within a few dollars of Luma Health's flat rates.
Where the Real Differences Are
✓ Eden offers a brand-name pathway; Luma Health doesn't. If you want FDA-approved Wegovy or Zepbound at Eden's cash rate (~$1,399–$1,695/month), Eden gives you that option under one roof.
✓ Both guarantee flat pricing regardless of dose. Eden's "same price at every dose" and Luma Health's flat rate are functionally the same commitment.
✗ Eden's pricing structure has been genuinely inconsistent. Multiple review sites report meaningfully different numbers for the same medication across 2026.
✗ Pharmacy naming is less specific at Eden. Eden references "state-licensed 503A compounding pharmacies" generally without naming a specific pharmacy and license number.
Side-by-Side: Eden vs. Luma Health
| Factor | Eden | Luma Health |
|---|---|---|
| Compounded semaglutide (current) | ~$198/mo combined | $197/mo flat |
| Compounded tirzepatide (current) | ~$298/mo combined | $297/mo flat |
| Brand-name option | Yes | No — compounded only |
| Pharmacy named publicly | General 503A reference | VialsRX TX #35264, verifiable |
Who Should Choose Eden vs. Luma Health
Given how much Eden's numbers have moved this year, the most useful thing you can do before enrolling anywhere is get the current price in writing — a screenshot of the checkout page, an email confirmation, anything that gives you a record of what you were actually quoted at signup.
- You want the option to move to brand-name medication later
- You're comfortable double-checking Eden's current live pricing before committing
- You want a broader menu including an oral, non-GLP-1 kit option
- You want one flat price with no separate membership line item
- You want a specific, state-board-verifiable pharmacy named before you pay
- You want pricing that hasn't shifted structure multiple times this year
One price, no membership fee. Compounded semaglutide is $197/month and tirzepatide is $297/month, flat, prepared by VialsRX, TX Board #35264, verifiable directly with the board. See all treatment options →
One price,
no membership fee
$197/month flat semaglutide. $297/month flat tirzepatide. VialsRX TX#35264.
Get Started → Or start your free health assessmentWhat the Clinical Evidence Supports
Whether you choose Eden or Luma Health, or any other provider, the underlying medications are the same class studied extensively in Phase 3 trials. Semaglutide's efficacy comes from the STEP program, including STEP 1, showing average weight reductions of roughly 15% over 68 weeks. Tirzepatide's efficacy comes from the SURMOUNT program, including SURMOUNT-1, with reductions ranging from 15% to nearly 21% depending on dose.
Neither Eden's "same price at every dose" model nor Luma Health's flat-rate structure changes the pharmacology of the medication itself. What differs between providers is exactly what this article has focused on: pricing transparency, pharmacy naming, and whether a brand-name pathway is available alongside the compounded option.
Frequently Asked Questions
Genuinely difficult to answer with certainty — figures range from about $99 to $249/month across 2026. As of the most recent figures, the combined total runs close to $198/month. Verify at tryeden.com.
Sources disagree. Several 2026 reviews report no membership fee; at least one more recent source describes a required $39 first-month, $99/month ongoing membership.
Close enough that price shouldn't be the deciding factor — both land within a few dollars of each other for semaglutide and tirzepatide.
No. Eden is cash-pay only, though HSA and FSA cards are accepted.
Yes, at cash-pay rates reported around $1,399–$1,695/month. Luma Health does not offer a brand-name pathway.
Eden references licensed 503A compounding pharmacy partners generally, without naming a specific pharmacy and license number publicly.
Reported terms describe cancel-anytime access through the patient portal with no long-term contract, though verify this directly given how much of Eden's other terms have shifted in 2026.
Eden's own materials describe broad U.S. availability, but state-specific access can vary based on pharmacy licensing and provider coverage. Confirm your state during Eden's intake process.
References
- Eden. GLP-1 Treatment and Pricing Page. tryeden.com
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. PubMed 33567185
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PubMed 35658024
- U.S. Food and Drug Administration. Human Drug Compounding — Section 503A. FDA.gov
- Texas State Board of Pharmacy. License Verification — VialsRX #35264. pharmacy.texas.gov